Radiofrequency ablation of unresectable hepatic tumors.
D054598:Blue Cross Blue Shield Insurance Plans; D017115:Catheter Ablation / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods; D018795:Device Approval; D006801:Humans; D019458:Insurance Coverage; D008113:Liver Neoplasms / Q000556:secondary / Q000601:surgery*; D009364:Neoplasm Recurrence, Local; D017063:Outcome Assessment, Health Care; D016032:Randomized Controlled Trials as Topic; D013673:Technology Assessment, Biomedical; D014481:United States; D014486:United States Food and Drug Administration